| Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex W Wei, NG Ayad, Y Wan, GJ Zhang, MW Kirschner, WG Kaelin Jr Nature 428 (6979), 194-198, 2004 | 547 | 2004 |
| Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. GJ Zhang, I Adachi Anticancer research 19 (2B), 1427-1432, 1999 | 426 | 1999 |
| Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist BZ Olenyuk, GJ Zhang, JM Klco, NG Nickols, WG Kaelin Jr, PB Dervan Proceedings of the National Academy of Sciences 101 (48), 16768-16773, 2004 | 277 | 2004 |
| Tamoxifen-induced Apoptosis in Breast Cancer Cells Relates to Down-Regulation of bcl-2, but not bax and bcl-XL, without Alteration of p53 Protein Levels GJ Zhang, I Kimijima, M Onda, M Kanno, H Sato, T Watanabe, A Tsuchiya, ... Clinical Cancer Research 5 (10), 2971-2977, 1999 | 228 | 1999 |
| Cell cycle regulation and anticancer drug discovery J Bai, Y Li, G Zhang Cancer biology & medicine 14 (4), 348, 2017 | 210 | 2017 |
| Critical protein GAPDH and its regulatory mechanisms in cancer cells JY Zhang, F Zhang, CQ Hong, AE Giuliano, XJ Cui, GJ Zhou, GJ Zhang, ... Cancer biology & medicine 12 (1), 10, 2015 | 182 | 2015 |
| circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3 axis JZ Xu, CC Shao, XJ Wang, X Zhao, JQ Chen, YX Ouyang, J Feng, ... Cell death & disease 10 (3), 175, 2019 | 178 | 2019 |
| Collagen 1A1 (COL1A1) promotes metastasis of breast cancer and is a potential therapeutic target J Liu, JX Shen, HT Wu, XL Li, XF Wen, CW Du, GJ Zhang Discovery medicine 25 (139), 211-223, 2018 | 168 | 2018 |
| Apoptotic index correlates to bcl-2 and p53 protein expression, histological grade and prognosis in invasive breast cancers GJ Zhang, I Kimijima, R Abe, T Watanabe, M Kanno, K Hara, A Tsuchiya Anticancer research 18 (3B), 1989-1998, 1998 | 121 | 1998 |
| Bioluminescent imaging of Cdk2 inhibition in vivo GJ Zhang, M Safran, W Wei, E Sorensen, P Lassota, N Zhelev, ... Nature medicine 10 (6), 643-648, 2004 | 119 | 2004 |
| The impact of p53 in predicting clinical outcome of breast cancer patients with visceral metastasis P Yang, CW Du, M Kwan, SX Liang, GJ Zhang Scientific reports 3 (1), 1-6, 2013 | 109 | 2013 |
| Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers M Koller, SQ Qiu, MD Linssen, L Jansen, W Kelder, J de Vries, I Kruithof, ... Nature communications 9 (1), 3739, 2018 | 97 | 2018 |
| Over-expressed twist associates with markers of epithelial mesenchymal transition and predicts poor prognosis in breast cancers via ERK and Akt activation YQ Zhang, XL Wei, YK Liang, WL Chen, F Zhang, JW Bai, SQ Qiu, CW Du, ... PloS one 10 (8), e0135851, 2015 | 91 | 2015 |
| Significance of interleukin-33 and its related cytokines in patients with breast cancers J Liu, JX Shen, JL Hu, WH Huang, GJ Zhang Frontiers in immunology 5, 141, 2014 | 88 | 2014 |
| Serum levels of soluble intercellular adhesion molecule-1 and E-selectin in metastatic breast carcinoma: correlations with clinicopathological features and prognosis. GJ Zhang, I Adachi International journal of oncology 14 (1), 71-78, 1999 | 87 | 1999 |
| A nomogram to predict the probability of axillary lymph node metastasis in early breast cancer patients with positive axillary ultrasound SQ Qiu, HC Zeng, F Zhang, C Chen, WH Huang, RG Pleijhuis, JD Wu, ... Scientific reports 6 (1), 1-12, 2016 | 83 | 2016 |
| Use of indocyanine green for detecting the sentinel lymph node in breast cancer patients: from preclinical evaluation to clinical validation C Chi, J Ye, H Ding, D He, W Huang, GJ Zhang, J Tian PloS one 8 (12), e83927, 2013 | 76 | 2013 |
| The role of bcl-2 expression in breast carcinomas GJ Zhang, I Kimijima, A Tsuchiya, R Abe Oncology reports 5 (5), 1211-1217, 1998 | 72 | 1998 |
| Adjuvant capecitabine with docetaxel and cyclophosphamide plus epirubicin for triple-negative breast cancer (CBCSG010): an open-label, randomized, multicenter, phase III trial J Li, K Yu, D Pang, C Wang, J Jiang, S Yang, Y Liu, P Fu, Y Sheng, ... Journal of Clinical Oncology 38 (16), 1774, 2020 | 70 | 2020 |
| Evolution in sentinel lymph node biopsy in breast cancer SQ Qiu, GJ Zhang, L Jansen, J de Vries, CP Schröder, EGE de Vries, ... Critical reviews in oncology/hematology 123, 83-94, 2018 | 70 | 2018 |
Gooitzen Michell van DamProfessor of Surgery, University of Groningen在 umcg.nl 的电子邮件经过验证
